Essential Amino Acid Metabolism-Related Molecular Classification in Triple-Negative Breast Cancer

Reference

• Bianchini G , BalkoJM , MayerIA , SandersME , GianniL. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol.13(11), 674–690 (2016).
   PubMed Web of Science ®Google Scholar
• Foulkes WD , SmithIE , ReisfilhoJS. Triple-negative breast cancer. N. Engl. J. Med.363(20), 1938–1948 (2010).
   PubMed Web of Science ®Google Scholar
• Zhou S , HuangYE , LiuHet al. Single-cell RNA-seq dissects the intratumoral heterogeneity of triple-negative breast cancer based on gene regulatory networks. Mol. Ther. Nucleic Acids23, 682–690 (2021).
   PubMedGoogle Scholar
• Lehmann BD , BauerJA , ChenXet al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest.121(7), 2750–2767 (2011).
   PubMed Web of Science ®Google Scholar
• Jiang YZ , LiuY , XiaoYet al. Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial. Cell Res.31(2), 178–186 (2021).
   PubMed Web of Science ®Google Scholar
• Zhang D , XuX , YeQ. Metabolism and immunity in breast cancer. Front. Med.15(3), 1–30 (2020).
   PubMedGoogle Scholar
• Koundouros N , PoulogiannisG. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer122(10), 1–19 (2019).
   PubMedGoogle Scholar
• Rosario SR , LongMD , AffrontiHCet al. Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas. Nat. Commun.9(1), 5330 (2018).
   PubMed Web of Science ®Google Scholar
• Terunuma A , PutluriN , MishraPet al. MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J. Clin. Invest.124(1), 398–412 (2014).
   PubMed Web of Science ®Google Scholar
• Gong Y , JiP , YangYSet al. Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets. Cell Metab.33(1), 51–64 (2021).
   PubMed Web of Science ®Google Scholar
• Warburg, O . On the origin of cancer cells. Oral Surg. Oral Med. Oral Pathol.10(4), 412–421 (1957).
   Google Scholar
• Hosios AM , HechtVC , DanaiLet al. Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev. Cell36(5), 540–549 (2016).
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ , MancusoA , DaikhinEet al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl Acad. Sci. USA104(49), 19345–19350 (2007).
   PubMed Web of Science ®Google Scholar
• Payne SH , LoomisWF. Retention and loss of amino acid biosynthetic pathways based on analysis of whole-genome sequences. Eukaryot. Cell5(2), 272–276 (2006).
   PubMedGoogle Scholar
• Hansen CG , NgY , LamWet al. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1. Cell Res.25(12), 1299–1313 (2015).
   PubMed Web of Science ®Google Scholar
• Jewell JL , RussellRC , GuanKL. Amino acid signaling upstream of mTOR. Nat. Rev. Mol. Cell Biol.14(3), 133–139 (2013).
   PubMed Web of Science ®Google Scholar
• Hattori A , TsunodaM , KonumaTet al. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia. Nature545(7655), 500–504 (2017).
   PubMed Web of Science ®Google Scholar
• Sheen JH , ZoncuR , KimDet al. Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell19(5), 613–628 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang H , WangY , LiJet al. Biosynthetic energy cost for amino acids decreases in cancer evolution. Nat. Commun.9(1), 4124–4139 (2018).
   PubMedGoogle Scholar
• Bian YJ , LiW , KremerDMet al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature585(7824), 277–282 (2020).
   PubMed Web of Science ®Google Scholar
• Leone RD , PowellJD. Metabolism of immune cells in cancer. Nat. Rev. Cancer20(9), 516–531 (2020).
   PubMed Web of Science ®Google Scholar
• Li X , WenesM , RomeroPet al. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat. Rev. Clin. Oncol.16, 425–441 (2019).
   PubMed Web of Science ®Google Scholar
• Butler M , MeerL , LeeuwenF. Amino acid depletion therapies: starving cancer cells to death. Trends Endocrinol. Metab.32(6), 367–381 (2021).
   PubMed Web of Science ®Google Scholar
• Hnzelmann S , CasteloR , GuinneyJ. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics14(1), 7 (2013).
   PubMedGoogle Scholar
• Mermel CH , SchumacherSE , HillBet al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol.12(4), 41 (2011).
   PubMed Web of Science ®Google Scholar
• Colaprico A , SilvaTC , OlsenCet al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res.44(8), e71 (2015).
   PubMed Web of Science ®Google Scholar
• Malta TM , SokolovA , GentlesAJet al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell173(2), 338–354 (2018).
   PubMed Web of Science ®Google Scholar
• Yoshihara K , ShahmoradgoliM , MartínezEet al. Inferring tumor purity and stromal and immune cell admixture from expression data. Nat. Commun.4, 2612 (2013).
   PubMed Web of Science ®Google Scholar
• Lehmann BD , JovanovićB , ChenXet al. Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection. PLoS ONE11(6), e0157368 (2016).
   PubMed Web of Science ®Google Scholar
• Hatzis C , PusztaiL , ValeroVet al. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA305(18), 1873–1881 (2011).
   PubMed Web of Science ®Google Scholar
• Chen PL , RohW , ReubenAet al. Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade. Cancer Discov.6(8), 827–837 (2016).
   PubMed Web of Science ®Google Scholar
• Alexandra S , TaviN , FuntSAet al. Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multiomic analysis. PLoS Med.14(5), e1002309 (2017).
   PubMed Web of Science ®Google Scholar
• Riaz N , HavelJJ , MakarovVet al. Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell171(4), 934–949 (2017).
   PubMed Web of Science ®Google Scholar
• Thom C , TraxlerE , KhandrosEet al. TRIM58 degrades dynein and regulates terminal erythropoiesis. Dev. Cell30(6), 688–700 (2014).
   PubMed Web of Science ®Google Scholar
• Min L , ZhangX , JianCet al. Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion. Oncol. Rep.40(3), 1251–1260 (2018).
   PubMed Web of Science ®Google Scholar
• Qiu X , HuangY , ZhouY , ZhengF. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication. Oncol. Rep.36(2), 811–818 (2016).
   PubMed Web of Science ®Google Scholar
• Koichiro K , KiyoshiM , TakuyaNet al. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma. Oncotarget8(2), 2890–2905 (2016).
   Google Scholar
• Gao X , SandersonSM , DaiZet al. Dietary methionine influences therapy in mouse cancer models and alters human metabolism. Nature572(7769), 397–401 (2019).
   PubMed Web of Science ®Google Scholar
• Saito Y , LiL , CoyaudEet al. LLGL2 rescues nutrient stress by promoting leucine uptake in ER+ breast cancer. Nature569(7755), 275–279 (2019).
   PubMed Web of Science ®Google Scholar
• Kanarek N , KeysHR , CantorJRet al. Histidine catabolism is a major determinant of methotrexate sensitivity. Nature559(7715), 632–636 (2018).
   PubMed Web of Science ®Google Scholar
• Sadik A , PattersonL , ZtürkSet al. IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression. Cell182(5), 1252–1270 (2020).
   PubMed Web of Science ®Google Scholar
• Yue M , JiangJ , GaoP , LiuH , QingG. Oncogenic MYC activates a feedforward regulatory loop promoting essential amino acid metabolism and tumorigenesis. Cell Rep.12(002), 3819–3832 (2017).
   Google Scholar
• Wolfson RL , SabatiniDM. The dawn of the age of amino acid sensors for the mTORC1 pathway. Cell Metab.26(2), 301–309 (2017).
   PubMed Web of Science ®Google Scholar
• Wolfson RL , ChantranupongL , SaxtonRAet al. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science351(6268), 43–48 (2016).
   PubMed Web of Science ®Google Scholar
• Fiamma M , LicioC , GianninoDS. Mutant p53 as a guardian of the cancer cell. Cell Death Differ.26(2), 199–212 (2018).
   PubMed Web of Science ®Google Scholar
• Hao Y , SamuelsY , LiQet al. Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer. Nat. Commun.7, 11971 (2016).
   PubMed Web of Science ®Google Scholar
• Theate I , BarenNV , PilotteLet al. Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues. Cancer Immunol. Res.3(2), 161–172 (2014).
   PubMed Web of Science ®Google Scholar
• Pilotte L , StroobantV , LarrieuPet al. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc. Natl Acad. Sci. USA109(7), 2497–2502 (2012).
   PubMed Web of Science ®Google Scholar
• Ming L , LiS , BrooksMDet al. Targeting breast cancer stem cell state equilibrium through modulation of redox signaling. Cell Metab.28(1), 69–86 (2018).
   PubMed Web of Science ®Google Scholar
• Jones CL , StevensBM , D’AlessandroAet al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell34(5), 724–740 (2018).
   PubMed Web of Science ®Google Scholar
• Wang Z , LianYY , JiaHet al. Methionine is a metabolic dependency of tumor-initiating cells. Nat. Med.25(5), 1–13 (2019).
   PubMed Web of Science ®Google Scholar
• Strekalova E , MalinD , WeisenhornEet al. S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells. Breast Cancer Res. Treat.175(1), 39–50 (2019).
   PubMed Web of Science ®Google Scholar
• Thakur C , ChenF. Connections between metabolism and epigenetics in cancers. Semin. Cancer Biol.57, 52–58 (2019).
   PubMed Web of Science ®Google Scholar
• Cheng C , XieZ , LiY , WangJ , QinC , ZhangY. PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis. Biomed. Pharmacother.108, 194–200 (2018).
   PubMed Web of Science ®Google Scholar
• Maschek G , SavarajN , PriebeWet al. 2-Deoxy-d-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res.64(1), 31–34 (2004).
   PubMed Web of Science ®Google Scholar
• Li J , ZhaoS , ZhouXet al. Inhibition of lipolysis by mercaptoacetate and etomoxir specifically sensitize drug-resistant lung adenocarcinoma cell to paclitaxel. PLoS ONE8(9), e74623 (2013).
   PubMed Web of Science ®Google Scholar
• Zhou Y , BolluLR , TozziFet al. ATP citrate lyase mediates resistance of colorectal cancer cells to SN38. Mol. Cancer Ther.12(12), 2782–2791 (2013).
   PubMed Web of Science ®Google Scholar
• Samudio I , HarmanceyR , FieglMet al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J. Clin. Invest.120(1), 142–156 (2010).
   PubMed Web of Science ®Google Scholar